BCAL Diagnostics (ASX:BDX) Dividends Received: A$0.00 Mil (TTM As of Dec. 2025)


What is BCAL Diagnostics Dividends Received?

BCAL Diagnostics ASX:BDX +1.39% Dividends Received is A$0.00 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

BCAL Diagnostics's Dividends Received for the six months ended in Dec. 2025 was A$0.00 Mil.

BCAL Diagnostics's Dividends Received for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00 Mil.

BCAL Diagnostics Dividends Received Related Terms

BCAL Diagnostics Dividends Received Historical Data

* Premium members only.

The historical data trend for BCAL Diagnostics's Dividends Received can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BCAL Diagnostics Dividends Received Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Dividends Received
0.00 0.00 0.00 0.00

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividends Received Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BCAL Diagnostics Dividends Received Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Dividends Received represents dividend received on the investment in the direct cash flow method.

Dividends Received for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividends Received →
What does a Dividends Received of A$0.00 Mil mean?
BCAL Diagnostics (ASX:BDX) has a Dividends Received of A$0.00 Mil as of Dec. 2025. Dividends Received represents dividend received on the investment in direct cash flow method. View historical data for BCAL Diagnostics and its competitors.
Is BCAL Diagnostics' Dividends Received too high?
BCAL Diagnostics' current Dividends Received is A$0.00 Mil.
How does BCAL Diagnostics' Dividends Received compare to TMO and DHR?
BCAL Diagnostics' Dividends Received of A$0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends Received for a Medical Diagnostics & Research company?
A good Dividends Received depends on the Medical Diagnostics & Research industry context. However, Dividends Received should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends Received mean?
A high Dividends Received can signal that a stock is expensive relative to its fundamentals. Dividends Received represents dividend received on the investment in direct cash flow method. View historical data for BCAL Diagnostics and its competitors. BCAL Diagnostics's current Dividends Received is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BCAL Diagnostics stock overvalued right now?
BCAL Diagnostics (ASX:BDX) has a current Dividends Received of A$0.00 Mil. The current Dividends Received is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends Received calculated?
Dividends Received is calculated from a company's financial statements. For BCAL Diagnostics (ASX:BDX), the current Dividends Received is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BCAL Diagnostics Business Description

Address 50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost-effective, accurate, and available to all women regardless of age, race, and geographic location.